By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Food and Drug Administration (FDA) 

5600 Fishers Lane

Rockville  Maryland  20857  U.S.A.
Phone: 888-463-6332 or 1-888-INFO-FDA (1-888-463-6332) Fax:

FDA Overview:

The Food and Drug Administration is one of the nation's oldest and most respected consumer protection agencies. This presentation will tell you about FDA's responsibilities, the tools we use to fulfill those responsibilities, and our priorities for improving the way we serve the public.

•Stated most simply, FDA's mission is:
- to promote and protect the public health by helping safe and effective products reach the market in a timely way,
- To monitor products for continued safety after they are in use, and
- To help the public get the accurate, science-based information needed to improve health.

FDA's Mission Statement

The FDA is responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation. The FDA is also responsible for advancing the public health by helping to speed innovations that make medicines and foods more effective, safer, and more affordable; and helping the public get the accurate, science-based information they need to use medicines and foods to improve their health.

Key Statistics

Ownership: Private

Web Site: FDA


Company News
Seqirus Receives FDA Approval For FLUAD (Influenza Vaccine, Adjuvanted) For Adults Aged 65 Years And Older 11/25/2015 10:09:57 AM
FDA Approves Emergent BioSolutions (EBS)' BioThrax For Post-Exposure Prophylaxis 11/25/2015 9:10:36 AM
Eli Lilly (LLY)'s New Cancer Drug Portrazza Wins FDA Approval 11/25/2015 6:26:11 AM
EDDA Technology Wins FDA Approval for IQQA-Guide 11/25/2015 6:19:47 AM
BioMarin (BMRN) Stock Halted as FDA Bashes Muscle Wasting Drug 11/25/2015 5:58:28 AM
Bristol-Myers Squibb (BMY) Receives FDA Approval For Opdivo (Nivolumab), The Only Treatment To Deliver Significant Overall Survival In Advanced Renal Cell Carcinoma Vs. A Standard Of Care, In Patients Who Have Received Prior Anti-Angiogenic Therapy1 11/24/2015 12:24:00 PM
Bristol-Myers Squibb (BMY) Announces U.S. FDA Approval For Opdivo (Nivolumab) As A Single Agent For The Treatment Of Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma 11/24/2015 12:20:27 PM
Lysogene Receives Orphan Drug Designation And Rare Pediatric Disease Designation From The FDA 11/24/2015 9:48:25 AM
Investors Hold Their Breath as BioMarin (BMRN)'s DMD Drug Gets Grilled by the FDA Today 11/24/2015 6:15:08 AM
Entellus Medical (ENTL) Snags FDA Approval for XprESS Multi-Sinus Dilation System in Pediatric Patients 11/24/2015 6:01:05 AM